Zumsemetinib: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

3

US states with sites

1

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Breast cancer	1
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer	1

Recruiting trials involving Zumsemetinib

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT06374459 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many recruiting trials involve Zumsemetinib?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.